NanoViricides Inc. (NNVC)

[Rawnoc]

DILUTION POLLUTION

April 20th, 2011 - NanoViricides Raises an Additional $5 Million in Shelf Offering - The Company Reports Having More than 24 Months of Cash in Hand

July 27th, 2011 - NanoViricides Raises $2.5M in Shelf Offering - The Company Reports Having More than 24 Months of Cash in Hand

November 3rd, 2011 - NanoViricides Raises an Additional $5 Million in Shelf Offering - The Company Reports Having More than 24 Months of Cash in Hand

June 29th, 2012 - NanoViricides Raises $5 Million in Shelf Offering - The Company Reports Having More than 24 Months of Cash in Hand

December 24th, 2012 - NanoViricides announces Completion of Previously Reported $5 Million in Shelf Offering - Company reports having more than two years of cash on hand

February 4th, 2013 - NanoViricides Raises $6M from Equity Investors - Reports Having Sufficient Funds for the Initial Human Clinical Trials of its Broad-spectrum anti-Influenza Drug

September 12th, 2013 - NanoViricides Announces that It Has Raised approximately $10.33 Million in the Registered Direct Offering Announced Recently and Discusses Shareholder Issues since the Reverse Split

January 21st, 2014 - NanoViricides Announces that It Has Raised $20 Million in a Registered Direct Offering